Inheritance of specific apolipoprotein E (apoE) alleles determines, in large part, the risk and mean age of onset of late-onset familial and sporadic Alzheimer disease. The mechanism by which the apoE isoforms differentially contribute to disease expression is, however, unknown. Isoform-specific differences have been identified in the binding of apoE to the microtubuleassociated protein T, which forms the paired helical filament and neurofibrillary tangles, and to amyloid 18 peptide, a major component of the neuritic plaque.
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These and other isoform-specific interactions of apoE give rise to testable hypotheses for the mechanism(s) of pathogenesis of Alzheimer disease. An unresolved issue of increasing importance is the relationship between the structural pathological lesions and the cellular pathogenesis responsible for the clinical disease phenotype, progressive dementia. The identification of apoE in the cytoplasm of human neurons and the characterization of isoform-specific binding of apoE to the microtubule-associated proteins T and MAP-2 present the possibility that apoE may affect microtubule function in the Alzheimer brain.
Alzheimer disease (AD) occurs in the later decades of life and is characterized by progressive dementia, the diffuse deterioration of mental function. Thought and memory processes are primarily affected; affective and behavioral changes may follow. The patient with AD experiences gradually increasing forgetfulness, decreasing attention span, and alterations in mood, often with frustration and agitation. As the disease progresses the patient ultimately cannot care for the simplest needs and becomes bedridden, totally dependent on caregivers. The interval between initial diagnosis and death can vary considerably, usually between 3 and 15 years.
In 1984, the work group of the National Institute of Communicative Diseases and Stroke and the Alzheimer's Disease and Related Disorders Association published criteria for the clinical diagnosis of AD that were based on features of the patient's history, physical and neurological examination, and laboratory investigations including brain imaging (1). These diagnostic criteria require the exclusion of other causes of memory loss and impaired cognitive function, such as multiple infarcts, intracranial mass lesions, infections, and toxic and metabolic disorders. Fulfilling these clinical criteria permits the diagnosis of possible or probable AD.
By the defined diagnostic criteria, the diagnosis of definite AD can be made only by microscopic examination of brain tissue, at either biopsy or, more commonly, autopsy. The neuropathologic criteria require the presence of neuritic plaques and neurofibrillary tangles (NFT), at specified densities (2) . The diagnosis of definite AD has therefore been defined by phenotypic neuropathological findings. The relationship between the neuritic plaques and NFT and the mechanism causing Alzheimer dementia is an unknown and controversial subject. Discovering the relationship between AD neuropathology and the pathogenesis of the disease is a central issue in developing and testing hypotheses to uncover the molecular and cellular mechanisms that ultimately result in the dementia.
APOE and AD
The delineation of the apolipoprotein E gene (APOE, gene; apoE, protein) in familial and sporadic AD can be viewed from two different vantage points: the emerging revolution of molecular genetics and the existing science of AD. The identification of APOE as a relevant genetic locus affecting the age of onset of AD represents an evolution of gene mapping technology developed over the past decade. This linkage involved the first application of nonparametric techniques to identify interesting chromosomal regions for susceptibility loci (3) .
There are three common alleles of APOE. APOE3 is the most common allele representing -78% of all chromosomes; APOE4, 15%; and APOE2, 7%. The proportion of different APOE alleles varies between racial and ethnic groups, particularly with regard to the relative proportions of APOE2 and APOE4 (4-7). In 1993 Strittmatter et al (8) T normally binds and stabilizes microtubules and promotes the assembly of microtubules by polymerizing tubulin. Microtubules are necessary for neurite extension and maintenance and for the transport of materials along the axon and dendrites in both orthograde and retrograde directions. In AD, T becomes abnormally phosphorylated and self-assembles into the pathological paired-helical filaments forming NFT (26) (27) (28) .
The topology and abundance of NFT in the brains of patients who meet neuritic plaque criteria for AD relate better to the dementia than do the plaques (29, 30) . This observation has fueled debate, particularly during the past decade, when plaques became the defined currency of diagnosis. Some forms of dementia have tangles but insufficient plaques for the diagnosis of AD. NFT are also present in neurons in other neurodegenerative diseases. NFT may represent a phenotype common to several neurodegenerative diseases and, rather than being nonspecific, provide clues to a common pathogenesis.
An important question is whether NFT themselves cause neuronal death or are simply phenotypic manifestations of dying cells. Arguments that NFT kill cells are aided by the rather obvious presence of this collection of intrusive material within the neurons. This association, however, does not provide evidence of pathogenesis. Recent studies have shown that apoE exists in many neurons in the hippocampus, only some of which contain NFT (31) . Since it is necessary to explain the primary role of a susceptibility gene, APOE, in AD, the apoE-containing neurons may represent a stage in the life of the neuron, with fully formed NFT representing one of the end points shortly before death. The age of onset of clinical disease is the variable most associated with inheritance of different APOE alleles (12, 13) . The number of NFT at the time of death did not differ in AD patients with APOE4/4 or APOE3/3 genotypes (22, 32) .
Testing of One Hypothesis
The effect of the inheritance of APOE genotypes has been widely and rapidly confirmed in >60 laboratories around the world. These confirmations do not, however, provide any additional data concerning the pathogenesis of disease. Multiple hypotheses can, and will, be generated. We hope that the testing of these hypotheses will provide insight into the mechanism of disease expression and opportunities to interdict with safe and effective therapies.
ApoE may perform multiple metabolic functions in the brain. ApoE is in the extracellular space as a free and as a bound protein. It is also found within some neurons, both in the cytoplasmic space and in the intravesicular space of endosomes, lysosomes, and peroxisomes (31, 33) . This multitude of sites suggests multiple metabolic functions. Not all of the functions of apoE may be relevant to its role in AD. Interactions that are qualitatively or quantitatively different involving the apoE isoforms are candidates for developing hypotheses of how the various APOE alleles differentially regulate disease expression. Several isoform-specific functions of apoE have already been characterized. These isoform-specific interactions include binding with the low density lipoprotein receptor, with AP3 peptide (34) , and with the microtubule-associated proteins T (35) and MAP-2 (36). The apoE Proc. NatL Acad Sci. USA 92 (1995) Proc. Natl Acad Sci USA 92 (1995) 4727 isoforms differentially determine neurite extension in cultured neurons (37) . Other isoform-specific interactions and functions of apoE in the brain will be identified.
The isoform-specific interactions of apoE with the microtubule-associated proteins T and MAP2c form the basis of a testable hypothesis (38) . These microtubule-associated proteins assist in the assembly and maintena,nce of microtubules in the neuronal cell body, axon, and dendrite. In vitro, apoE2' and apoE3, but not apoE4, bind to the microtubule binding domains of T and MAP2c. Binding of these microtubule-associated proteins by apoE2 and apoE3 may stabilize their interactions with P3-tubulin and thereby stabilize the microtubule. Binding of apoE2 and apoE3 to T may also inhibit the ability of T to self-associate in the formation of paired helical filaments. Time-dep,endent failure of microtubule structure and function can lead to loss of normal transport functions, withdrawal and simplification of synapses, accelerated death of neurons, appearance of NFT in the sickest cells, and neuritic plaques in 'sites of distal dendritic atrophy. Because of an independent difference in the interaction of' the apoE isoforms with A,B, differences in plaque density are also observed as another phenotypic consequence.
Summary
Considerable genetic evidence supports the role ofAPOE in the distribution of age of onset of AD. Testing of hypothetical mechanisms is just beginn ing. The examination of apoE isoform-specific biology and biochemistry' will shed considerable light on the mechanisms of pathogenesis of AD. By using 'a genetic framnework, phenotypic manifestations associated with disease expression can also be explained. Testing mechanisms of pathogenesis will lead to the identification of putative targets for therapeutic intervention.
